Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7B consumer brands deal

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
StockStory.org on MSN

Kforce’s (NYSE:KFRC) Q3 Sales Beat Estimates, Stock Jumps 14.1%

Professional staffing firm Kforce (NYSE:KFRC) announced in Q3 CY2025, but sales fell by 5.9% year on year to $332.6 million.

Canadian Pacific Kansas City: Initiating A Buy Following Q3 Results

Discover why Canadian Pacific Kansas City’s unique rail network and strong earnings growth make it a top Buy for investors.

Crane Harbor Stock Rise on Merger Deal with Xanadu Quantum Technologies

Crane Harbor Acquisition Corp (NASDAQ:CHAC) rose Monday after the company announced a merger deal with Xanadu Quantum Technologies to form a dedicated photonic quantum computing firm.

Kimberly-Clark to Buy Tylenol Maker Kenvue. Why Kimberly-Clark Stock Is Tanking.

Kimberly-Clark agreed to buy Kenvue in a cash-and-stock transaction that values the Tylenol maker at an enterprise value of ...
Zacks Investment Research on MSN

Why Kinross Gold (KGC) is a Top Growth Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...